Cvs Health CORP (CVS) — Institutional Holders Breakdown (Q2 2026)

CVS ranks #131 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

CVS is a top-conviction position for Glenview Capital Management, LLC — at 9.1% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in CVS belongs to BlackRock, Inc., but the position matters far more to Glenview Capital Management, LLC, who has 9.1% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Assenagon Asset Management S.A. has added to its CVS position for two straight quarters, increasing it by $263.8M to reach $326.7M today.

Stolper Co has trimmed its CVS position for two straight quarters, cutting it by $5.7M while still holding $2.4M.

CVS is down 0.2% today, but institutions show net buying of $21.7B this quarter — a divergence between today's price move and the underlying institutional flow.

CVS posted net income of $4.9B over the trailing twelve months, and currently trades at a P/E of 24.0.

• Profitable — net income of $4.9B over the trailing twelve months
• Revenue grew 7.4% year over year
• Net income improved year over year, from $4.5B to $4.9B
• Generated $10.6B in positive operating cash flow
• Current ratio of 0.84x — below the conventional 1.5x liquidity buffer
• Liabilities run 2.37x equity — a highly leveraged balance sheet worth noting